Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan in non-dialysis CKD stage 3b-5 with mild to moderate hypertension
ChiCTR2100050673Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sacubitril + valsartan in chronic kidney disease (CKD) and essential hypertension (2 arms), sponsored by The Third Affiliated Hospital of Southern Medical University. Primary endpoint: Change in eGFR from baseline at end of follow-up. Started Sep 2021; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
chronic kidney disease (CKD)essential hypertension
Beyond the preview
Go deeper on ChiCTR2100050673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050673.